Recruiting

Observational Study

Sponsor:

Northwell Health

Code:

NCT00902447

Conditions

Human Blood Cell Disorders

Lymphoid, Myeloid and Erythroid Proliferative Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in these disorders. Internal and external investigators will be able to utilize this tissue to test hypotheses relating to the immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as normal cells from normal unaffected family members or normal aged matched subjects to provide better comparisons.

Conditions

Human Blood Cell Disorders

Lymphoid, Myeloid and Erythroid Proliferative Disease

Study ID

NCT00902447

Start date

Apr, 2009

Status verified date

Nov, 2026

Completion date

Jan, 2035

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Participants or participant's Legally Authorized Representatives (LAR) must be able to understand and render voluntary, written informed consent.
  • Patients must be able to contribute the required amount of blood and/or tissue without compromising their well-being or care.
  • Participants must be willing to be contacted again for consideration of additional studies in the future, such as a blood draw or another action (e.g., bone marrow aspiration and/or biopsy) that would be done as part of their standard of care.

Exclusion Criteria:

  • Patients who are known to be anemic, with hemoglobin <8.0g/dl.
  • Patients who are known to be infected with HIV.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Human Blood Cell Disorders

Human Blood Cell Disorders Tissue Bank

Primary outcome measure

  • Accumulate tissue from patients with various blood disorders, including but not restricted to lymphoproliferative, myeloproliferative, and erythroproliferative conditions. [ Time Frame: Indefinite ]

Central Contacts and Locations

Central contacts

Yasmine Kieso, MSCR

ykieso@northwell.edu

Locations

The Feinstein Institute for Medical Research

Recruiting

Manhasset, New York, United States, 11030

Contacts

Yasmine Kieso, MSCR

ykieso@northwell.edu

Principal Investigator:

Nicholas Chiorazzi, M.D.

More Information

Sponsor

Northwell Health

Last update posted

Nov 20, 2026

Last verified

Nov, 2026

Keywords

  • Human Blood Cell Disorders
  • lymphoid, myeloid and erythroid proliferative disease

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Northwell Health on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.